Structures by: Black S. N.
Total: 23
(1R, 2S)-(-)-ephedrine besylate
C16H20O4S1
Acta Crystallographica Section B (2006) 62, 3 498-505
a=5.7214(3)Å b=20.8336(11)Å c=6.9188(5)Å
α=90° β=98.409(2)° γ=90°
(1R, 2S)-(-)-ephedrine adipate
C16H25N1O5
Acta Crystallographica Section B (2006) 62, 3 498-505
a=5.82900(10)Å b=13.5440(4)Å c=21.7000(7)Å
α=90° β=90° γ=90°
(1R, 2S)-(-)-ephedrine acetate
C12H19N1O3
Acta Crystallographica Section B (2006) 62, 3 498-505
a=5.96420(10)Å b=10.4125(2)Å c=11.7403(4)Å
α=108.1750(10)° β=104.5600(10)° γ=104.087(2)°
(1R, 2S)-(-)-ephedrine edisylate
C22H36N2O8S2
Acta Crystallographica Section B (2006) 62, 3 498-505
a=5.71080(10)Å b=34.0651(7)Å c=6.6590(2)Å
α=90° β=90.09° γ=90°
(1R, 2S)-(-)-ephedrine
C10H16N1O1
Acta Crystallographica Section B (2006) 62, 3 498-505
a=5.6851(4)Å b=7.7047(5)Å c=22.4819(17)Å
α=90° β=90° γ=90°
(1R, 2S)-(-)-ephedrine esylate
C12H21N1O4S1
Acta Crystallographica Section B (2006) 62, 3 498-505
a=5.4877(7)Å b=11.9057(17)Å c=22.639(4)Å
α=90° β=90° γ=90°
(1R, 2S)-(-)-ephedrine hydrochloride
C10H14Cl1N1O1
Acta Crystallographica Section B (2006) 62, 3 498-505
a=7.2557(3)Å b=6.1228(3)Å c=12.5486(6)Å
α=90° β=102.223(2)° γ=90°
(1R, 2S)-(-)-ephedrine L-(-)-malate
C14H21N1O6
Acta Crystallographica Section B (2006) 62, 3 498-505
a=6.1312(6)Å b=9.1719(10)Å c=13.7393(17)Å
α=90° β=100.909(4)° γ=90°
(1R, 2S)-(-)-ephedrine maleate monohydrate
C12H12N1O4
Acta Crystallographica Section B (2006) 62, 3 498-505
a=5.6370(2)Å b=13.4950(5)Å c=20.5250(5)Å
α=90° β=90° γ=90°
(1R, 2S)-(-)-ephedrine mesylate
C11H19N1O4S1
Acta Crystallographica Section B (2006) 62, 3 498-505
a=14.287(2)Å b=6.1075(7)Å c=14.993(2)Å
α=90° β=93.211(6)° γ=90°
(1R, 2S)-(-)-ephedrine dihydrogen phosphate
C10H16N1O5P1
Acta Crystallographica Section B (2006) 62, 3 498-505
a=14.6992(10)Å b=5.6433(4)Å c=15.2432(14)Å
α=90° β=97.333(3)° γ=90°
(1R, 2S)-(-)-ephedrine bisulfate
C10H18N1O5S1
Acta Crystallographica Section B (2006) 62, 3 498-505
a=30.9967(17)Å b=6.9861(4)Å c=5.6170(3)Å
α=90° β=93.354(3)° γ=90°
(1R, 2S)-(-)-ephedrine L-(+)-tartrate monohydrate
C14H23N1O8
Acta Crystallographica Section B (2006) 62, 3 498-505
a=6.6220(2)Å b=7.4620(3)Å c=33.2160(15)Å
α=90° β=90° γ=90°
(1R, 2S)-(-)-ephedrine P-tosylate
C17H23N1O7S1
Acta Crystallographica Section B (2006) 62, 3 498-505
a=5.7491(2)Å b=7.1665(2)Å c=42.0343(9)Å
α=90° β=90° γ=90°
(1R, 2S)-(-)-ephedrine malonate
C11H17N1O3
Acta Crystallographica Section B (2006) 62, 3 498-505
a=15.1190(14)Å b=5.7840(7)Å c=13.8788(15)Å
α=90° β=105.765(7)° γ=90°
C20H13NO4
C20H13NO4
Acta Crystallographica Section C (1992) 48, 2 321-323
a=14.972(3)Å b=5.1410(10)Å c=19.853(3)Å
α=90° β=94.15(2)° γ=90°
C17H17ClN4O2
C17H17ClN4O2
Acta Crystallographica Section C (1992) 48, 2 323-325
a=7.586(2)Å b=11.429(4)Å c=19.592(8)Å
α=90° β=93.52(3)° γ=90°
Piperidine Hydrate
C18H21ClF2N3O5
Crystal Growth & Design (2004) 4, 3 539
a=21.6750(10)Å b=5.8970(10)Å c=16.1290(10)Å
α=90.000(10)° β=115.100(10)° γ=90.000(10)°
Piperidine anhydrate
C18H18ClF2N3O4
Crystal Growth & Design (2004) 4, 3 539
a=12.770(1)Å b=9.931(1)Å c=15.560(1)Å
α=90.00(1)° β=107.95(1)° γ=90.00(1)°
(1R, 2S)-(-)-ephedrine glycolate
C12H19N1O4
Acta Crystallographica Section B (2006) 62, 3 498-505
a=9.5946(4)Å b=6.0474(3)Å c=10.8255(5)Å
α=90° β=101.607(2)° γ=90°
(1R, 2S)-(-)-ephedrine hemihydrate
C10H15N1O1
Acta Crystallographica Section B (2006) 62, 3 498-505
a=7.3639(4)Å b=11.2551(6)Å c=24.1442(16)Å
α=90° β=90° γ=90°
(1R, 2S)-(-)-ephedrine nitrate
C10H14N2O4
Acta Crystallographica Section B (2006) 62, 3 498-505
a=5.5309(4)Å b=6.8501(6)Å c=15.6906(13)Å
α=90° β=97.243(6)° γ=90°
(1R, 2S)-(-)-ephedrine L-(+)-tartrate trihydrate
C24H42N2O11
Acta Crystallographica Section B (2006) 62, 3 498-505
a=5.9373(2)Å b=7.0594(2)Å c=18.3791(8)Å
α=80.2540(10)° β=88.527(2)° γ=66.247(2)°